Literature DB >> 16998657

[Importance of anesthesia in multimodal oncologic therapeutical concepts].

J Weitz1, M A Weigand, P Kienle, D Jäger, M W Büchler, E Martin.   

Abstract

Patients with malignant diseases are increasingly being treated with multimodal therapeutical concepts based on the three major modalities surgery, radiotherapy and chemotherapy. The perioperative period is crucial within this multimodal concept as the prognosis of patients may be directly influenced by perioperative measures. In addition, it is of major importance to avoid complications in the perioperative phase, as these might worsen the prognosis of the patient and in order to prevent a delay in the beginning of planned adjuvant therapies. These aspects demonstrate the important role of anesthesia in the treatment of patients with cancer. Further studies defining the relevance of anesthesiologic measures in oncologic patients are needed.

Entities:  

Mesh:

Year:  2006        PMID: 16998657     DOI: 10.1007/s00101-006-1091-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  66 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 2.  Mechanisms of transfusion-induced immunosuppression.

Authors:  M E Brunson; J W Alexander
Journal:  Transfusion       Date:  1990-09       Impact factor: 3.157

3.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

4.  Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer.

Authors:  Masashi Takemura; Harushi Osugi; Masayuki Higashino; Nobuyasu Takada; Sigeru Lee; Hiroaki Kinoshita
Journal:  Ann Thorac Cardiovasc Surg       Date:  2005-10       Impact factor: 1.520

5.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  [Leukocyte filtration in elective colorectal surgery. Reduced transfusion associated immunosuppression after bedside procedures].

Authors:  L S Jensen; M E Hokland; H J Nielsen
Journal:  Ugeskr Laeger       Date:  1997-08-18

7.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Is gastric carcinoma different between Japan and the United States?

Authors:  Y Noguchi; T Yoshikawa; A Tsuburaya; H Motohashi; M S Karpeh; M F Brennan
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

Review 9.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

View more
  1 in total

1.  [Anesthesiology: partner or competitor?].

Authors:  C M Körner; M A Weigand; E Martin
Journal:  Chirurg       Date:  2012-04       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.